AI Safety, Ethics & Governance

What if the most advanced safety framework isn’t in code, but in the way we silence hidden threats at the molecular level? A groundbreaking study published in Nature Biomedical Engineering on September 21, 2026, details a gene-tagging therapy (CRMA-1001) that uses epigenetic editing to silence hepatitis B virus DNA in human cells, mice, and monkeys—without cutting the genome. The therapy, developed by nChroma Bio and the San Raffaele Telethon Institute, achieved 'quite impressive' results with minimal side effects. This model—turning off threats rather than destroying them—offers a powerful metaphor for AI safety: how do we neutralize latent risks in models, data, or systems without irreversible damage? The lesson is clear: long-term safety requires addressing the archive. This breakthrough is not just medical—it’s a blueprint for non-destructive risk mitigation in high-stakes systems. Source: https://www.nature.com/articles/d41586-026-02981-9?error=cookies_not_supported&code=559f3bab-5d95-4f55-a9fa-93be6fcda7fd View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.